542934
CBPL
Start SIP
Invest Now
Start SIP in CBPL
Performance
- Low
- ₹39
- High
- ₹40
- 52 Week Low
- ₹33
- 52 Week High
- ₹73
- Open Price₹40
- Previous Close₹41
- Volume2,000
- 50 DMA₹47.79
- 100 DMA₹55.06
- 200 DMA₹67.30
Investment Returns
- Over 1 Month -10.93%
- Over 3 Month -8.86%
- Over 6 Month -32.37%
- Over 1 Year -42.37%
Smart Investing Starts Here Start SIP with Chandra Bhagat Pharma for Steady Growth!
Chandra Bhagat Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 34.5
- PEG Ratio
- -
- Market Cap Cr
- 30
- P/B Ratio
- 1
- Average True Range
- 3.18
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -2.54
- RSI
- 40.57
- MFI
- 54.24
Chandra Bhagat Pharma Financials
Chandra Bhagat Pharma Technicals
EMA & SMA
Current Price
₹39.19
-2.06
(-4.99%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹42.76
- 50 Day
- ₹47.79
- 100 Day
- ₹55.06
- 200 Day
- ₹67.30
Resistance and Support
39.43
- R3 40.37
- R2 40.14
- R1 39.66
- S1 38.95
- S2 38.72
- S3 38.24
Chandra Bhagat Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Half Yearly Results | |
| 2025-05-29 | Audited Results | |
| 2024-11-13 | Half Yearly Results | |
| 2024-05-30 | Audited Results | |
| 2023-11-09 | Half Yearly Results |
Chandra Bhagat Pharma F&O
About Chandra Bhagat Pharma
- NSE Symbol
- CBPL
- BSE Symbol
- 542934
- Chairman & Managing Director
- Mr. Hemant Chandravadan Bhagat
- ISIN
- INE07QQ01016
Similar Stocks to Chandra Bhagat Pharma
Chandra Bhagat Pharma FAQs
Chandra Bhagat Pharma share price is ₹39 As on 12 January, 2026 | 08:12
The Market Cap of Chandra Bhagat Pharma is ₹29.6 Cr As on 12 January, 2026 | 08:12
The P/E ratio of Chandra Bhagat Pharma is 34.5 As on 12 January, 2026 | 08:12
The PB ratio of Chandra Bhagat Pharma is 1 As on 12 January, 2026 | 08:12
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.